Ruffer LLP’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Ruffer LLP’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,000	Closed	-$6K	–	74
2017 Q1	$6K	Hold	14,000	–	–	﹤0.01%	68
2016 Q4	$5K	Hold	14,000	–	–	﹤0.01%	77
2016 Q3	$4K	Hold	14,000	–	–	﹤0.01%	80
2016 Q2	$3K	Hold	14,000	–	–	﹤0.01%	78
2016 Q1	$1K	Hold	14,000	–	–	﹤0.01%	85
2015 Q4	$2K	Hold	14,000	–	–	﹤0.01%	94
2015 Q3	$3K	Hold	14,000	–	–	﹤0.01%	93
2015 Q2	$10K	Hold	14,000	–	–	﹤0.01%	94
2015 Q1	$9K	Hold	14,000	–	–	﹤0.01%	93
2014 Q4	$11K	Hold	14,000	–	–	﹤0.01%	89
2014 Q3	$7K	Hold	14,000	–	–	﹤0.01%	85
2014 Q2	$7K	Hold	14,000	–	–	﹤0.01%	93
2014 Q1	$4K	Buy	+14,000	New	+$5.2K	﹤0.01%	99

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Ruffer LLP's GCVRZ Position: Q2 2017 in Review

Ruffer LLP sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2017, closing a stake of 14,000 shares — an estimated $6K sold.

Ruffer LLP first reported a position in GCVRZ in Q1 2014 and held it in 13 quarters. The position peaked at $11K in Q4 2014. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2017.

Ruffer LLP reported no remaining Sanofi Contingent Value Rights position as of Q2 2017 after selling out during the quarter.
Ruffer LLP sold 14,000 Sanofi Contingent Value Rights shares in Q2 2017, an estimated $6K.
Ruffer LLP first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 13 quarters.
Ruffer LLP's Sanofi Contingent Value Rights position peaked at $11K in Q4 2014.
115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2017.

Based on Ruffer LLP's 13F filing for Q2 2017, filed 11 Aug 2017.